159,892 results match your criteria Lancet[Journal]


Planetary Health Alliance 2019 call for abstracts.

Lancet Planet Health 2019 Feb 15. Epub 2019 Feb 15.

Division of Infectious Diseases and Geographic Medicine, Woods Institute for the Environment, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2542-5196(19)30022-1DOI Listing
February 2019

Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study.

Lancet HIV 2019 Feb 15. Epub 2019 Feb 15.

Department of Haematology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.

Background: The risk of venous thrombotic events is elevated in people with HIV, but overall risk estimates and estimates specific to immune status and antiretroviral medication remain i mprecise. In this study, we aimed to estimate these parameters in a large cohort of people with HIV in the Netherlands.

Methods: In this retrospective cohort study, we used the Dutch ATHENA cohort to estimate crude, age and sex standardised, and risk period-specific incidences of a first venous thrombotic event in people with HIV aged 18 years or older attending 12 HIV treatment centres in the Netherlands. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30333-3DOI Listing
February 2019

Strategies for engaging men in HIV services.

Lancet HIV 2019 Feb 15. Epub 2019 Feb 15.

Division of Social and Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. Electronic address:

The importance of men in the global HIV response is increasingly recognised. In most settings, men are less engaged in HIV services and have worse health outcomes than women. The multiple gender, social, economic, political, and institutional factors behind these patterns are well documented. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(19)30032-3DOI Listing
February 2019

Is HIV a provoking factor for venous thrombotic events?

Lancet HIV 2019 Feb 15. Epub 2019 Feb 15.

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30363-1DOI Listing
February 2019

Molecular biomarkers for the evaluation of lung nodules.

Authors:
Peter J Mazzone

Lancet Respir Med 2019 Feb 15. Epub 2019 Feb 15.

Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30528-9DOI Listing
February 2019

Intracerebral haemorrhage during alemtuzumab administration.

Lancet Neurol 2019 Feb 15. Epub 2019 Feb 15.

College Park Family Care Center, Overland Park, KS, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30076-6DOI Listing
February 2019

Correction to Lancet Infect Dis 2017; 17: 330-38.

Authors:

Lancet Infect Dis 2019 Feb 15. Epub 2019 Feb 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(19)30079-9DOI Listing
February 2019

Ebola virus disease.

Lancet 2019 Feb 15. Epub 2019 Feb 15.

Institute of Tropical Medicine, Antwerp, Belgium.

Ebolaviruses are pathogenic agents associated with a severe, potentially fatal, systemic disease in man and great apes. Four species of ebolaviruses have been identified in west or equatorial Africa. Once the more virulent forms enter the human population, transmission occurs primarily through contact with infected body fluids and can result in major epidemics in under-resourced settings. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)33132-5DOI Listing
February 2019

Fetal origins of postnatal growth faltering in HIV-exposed uninfected children.

Lancet Child Adolesc Health 2019 Feb 14. Epub 2019 Feb 14.

Massachusetts General Hospital, Departments of Medicine and Pediatrics, Boston, MA, USA; Harvard T. H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-4642(19)30023-9DOI Listing
February 2019

Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.

Lancet Child Adolesc Health 2019 Feb 14. Epub 2019 Feb 14.

Division of Epidemiology and Biostatistics, University of Cape Town, Cape Town, South Africa; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.

Background: Over 1 million HIV-exposed uninfected (HEU) children are born in sub-Saharan Africa annually. Little data exist on the risk of impaired growth in this population under current policies of universal maternal antiretroviral therapy (ART) with breastfeeding. We aimed to study the growth of breastfed HEU children born to women who initiated ART during pregnancy and compare their growth with that of breastfed HIV-unexposed (HU) children drawn from the same community. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-4642(19)30007-0DOI Listing
February 2019

An unparalleled assessment of the global burden of epilepsy.

Authors:
W Allen Hauser

Lancet Neurol 2019 Feb 14. Epub 2019 Feb 14.

Sergievsky Center, Columbia University, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30042-0DOI Listing
February 2019

Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors:

Lancet Neurol 2019 Feb 14. Epub 2019 Feb 14.

Background: Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality and residual disability). Data on the burden of epilepsy are needed for health-care planning and resource allocation. The aim of this study was to quantify health loss due to epilepsy by age, sex, year, and location using data from the Global Burden of Diseases, Injuries, and Risk Factors Study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(18)30454-XDOI Listing
February 2019
21.896 Impact Factor

Immune response to non-HLA antigens and renal allograft loss.

Authors:
Stanley C Jordan

Lancet 2019 Feb 14. Epub 2019 Feb 14.

Comprehensive Transplant Center, Cedars-Sinai Medical Center, West Hollywood, CA 90048, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)33186-6DOI Listing
February 2019

Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.

Lancet 2019 Feb 14. Epub 2019 Feb 14.

Department of Nephrology, Medical University of Vienna, Vienna, Austria. Electronic address:

Background: The introduction of HLA matching of donors and recipients was a breakthrough in kidney transplantation. However, half of all transplanted kidneys still fail within 15 years after transplantation. Epidemiological data suggest a fundamental role of non-HLA alloimmunity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)32473-5DOI Listing
February 2019

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.

Lancet 2019 Feb 14. Epub 2019 Feb 14.

Department of Women and Children's Health, King's College London, London, UK. Electronic address:

Background: Intrahepatic cholestasis of pregnancy is associated with adverse perinatal outcomes, but the association with the concentration of specific biochemical markers is unclear. We aimed to quantify the adverse perinatal effects of intrahepatic cholestasis of pregnancy in women with increased serum bile acid concentrations and determine whether elevated bile acid concentrations were associated with the risk of stillbirth and preterm birth.

Methods: We did a systematic review by searching PubMed, Web of Science, and Embase databases for studies published from database inception to June 1, 2018, reporting perinatal outcomes for women with intrahepatic cholestasis of pregnancy when serum bile acid concentrations were available. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736183187
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(18)31877-4DOI Listing
February 2019
3 Reads

Management of intrahepatic cholestasis in pregnancy.

Lancet 2019 Feb 14. Epub 2019 Feb 14.

Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC 3168, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)32323-7DOI Listing
February 2019
45.217 Impact Factor

Good outcomes for patients with classical Hodgkin lymphoma.

Authors:
Elizabeth Gourd

Lancet Oncol 2019 Feb 14. Epub 2019 Feb 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30069-5DOI Listing
February 2019

UK health tourism for private cancer care.

Authors:
Talha Khan Burki

Lancet Oncol 2019 Feb 14. Epub 2019 Feb 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30070-1DOI Listing
February 2019

Providers should discuss U=U with all patients living with HIV.

Lancet HIV 2019 Feb 13. Epub 2019 Feb 13.

Harvard Medical School and The Fenway Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(19)30030-XDOI Listing
February 2019

Putting participants at the centre of HIV cure research.

Lancet HIV 2019 Feb 13. Epub 2019 Feb 13.

Collaboratory of AIDS Researchers for Eradication Community Advisory Board, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; HIV and Aging Research Project-Palm Springs, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(19)30031-1DOI Listing
February 2019

Paediatric pulmonary embolism: a pathway to improved outcomes.

Authors:
Vera Ignjatovic

Lancet Haematol 2019 Feb 13. Epub 2019 Feb 13.

Murdoch Children's Research Institute and Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, VIC 3052, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30012-2DOI Listing
February 2019

Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.

Lancet Haematol 2019 Feb 13. Epub 2019 Feb 13.

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address:

Background: Little is known about severe pulmonary embolism in children. We aimed to report pulmonary embolism outcomes, identify risk factors for unfavourable outcomes, and evaluate the discriminative ability of two clinical-severity indices in children.

Methods: In this retrospective cohort study, we included consecutive patients aged 18 years or younger with acute pulmonary embolism, objectively diagnosed radiologically or pathologically, between Jan 1, 2000, and Dec 31, 2016, from two Canadian paediatric hospitals (The Hospital for Sick Children, Toronto, ON, and the Children's Hospital of Eastern Ontario, Ottawa, ON). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30224-2DOI Listing
February 2019

Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.

Lancet Respir Med 2019 Feb 13. Epub 2019 Feb 13.

Departments of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Thoracic Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address:

Background: In patients with non-expandable lung, removal of pleural fluid can result in excessively negative pleural pressure, which is associated with chest discomfort, pneumothorax, and re-expansion pulmonary oedema. Pleural manometry is widely used to safeguard against pressure-related complications during thoracentesis despite little evidence to support the approach. We investigated whether monitoring of pleural pressure with manometry during thoracentesis could protect against complications compared with assessment of symptoms alone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30421-1DOI Listing
February 2019

Pleural manometry and thoracentesis-is the issue resolved?

Lancet Respir Med 2019 Feb 13. Epub 2019 Feb 13.

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22132600193003
Publisher Site
http://dx.doi.org/10.1016/S2213-2600(19)30033-5DOI Listing
February 2019
4 Reads

Superpowers instead.

Authors:
Kelley Swain

Lancet Child Adolesc Health 2019 Mar;3(3):145-146

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-4642(19)30038-0DOI Listing

The fate of families separated at the US border.

Lancet Child Adolesc Health 2019 Mar;3(3):129

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-4642(19)30035-5DOI Listing

Should efavirenz be used in children and, if so, how?

Lancet HIV 2019 Feb 12. Epub 2019 Feb 12.

Department of Paediatrics and Child Health FAM-CRU, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30337-0DOI Listing
February 2019

Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study.

Lancet HIV 2019 Feb 12. Epub 2019 Feb 12.

Department of Paediatrics, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Background: Efavirenz is commonly prescribed for children with HIV infection, yet little is known about risks of neuropsychiatric side-effects. We aimed to compare competence (social involvement, activities, and school performance) and psychopathology (internalising and externalising problems), cognitive performance (intelligence and working memory), and adherence in Tanzanian children on an efavirenz-based versus a non-efavirenz-based regimen.

Methods: In this multicentre, cross-sectional, observational study, we included consecutive children (aged 6-12 years) with HIV infection, on combination antiretroviral therapy (cART) for at least 6 months, and with viral loads of less than 1000 copies per mL from HIV care clinics of three primary health facilities and three referral hospitals in Moshi, Kilimanjaro, Tanzania. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30329-1DOI Listing
February 2019

Urgent action on antimicrobial resistance.

Authors:
Susan Rahimi

Lancet Respir Med 2019 Feb 12. Epub 2019 Feb 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30031-1DOI Listing
February 2019

Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.

Lancet Oncol 2019 Feb 12. Epub 2019 Feb 12.

University College London Cancer Institute, London, UK.

Background: In the PROSPER trial, enzalutamide significantly improved metastasis-free survival in patients with non-metastatic, castration-resistant prostate cancer. Here, we report the results of patient-reported outcomes of this study.

Methods: In the randomised, double-blind, placebo-controlled, phase 3 PROSPER trial, done at 254 study sites worldwide, patients aged 18 years or older with non-metastatic, castration-resistant prostate cancer and a prostate-specific antigen doubling time of up to 10 months were randomly assigned (2:1) via an interactive voice web recognition system to receive oral enzalutamide (160 mg per day) or placebo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30898-2DOI Listing
February 2019

CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer.

Lancet Oncol 2019 Feb 12. Epub 2019 Feb 12.

Division of Radiation Oncology, London Health Sciences Centre, London, ON N6A4L6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30953-7DOI Listing
February 2019

Effective and well tolerated: where do these drugs fit now?

Lancet Oncol 2019 Feb 12. Epub 2019 Feb 12.

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3000, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30901-XDOI Listing
February 2019

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Lancet Oncol 2019 Feb 12. Epub 2019 Feb 12.

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Background: Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective evidence that this type of treatment improves local control or prolongs overall survival compared with standard radiotherapy. We aimed to compare the two treatment techniques.

Methods: We did this multicentre, phase 3, randomised, controlled trial in 11 hospitals in Australia and three hospitals in New Zealand. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30896-9DOI Listing
February 2019

Correction to Lancet Glob Health 2019; 7: e236-48.

Authors:

Lancet Glob Health 2019 Feb 12. Epub 2019 Feb 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2214-109X(19)30016-6DOI Listing
February 2019

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

Lancet Psychiatry 2019 Feb 11. Epub 2019 Feb 11.

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address:

Background: Early immunotherapy administration improves outcomes in patients with N-methyl-D-aspartate receptor (NMDAR)-antibody encephalitis. As most patients with NMDAR-antibody encephalitis present to psychiatrists, the psychopathology of NMDAR-antibody encephalitis needs to be clearly defined to encourage accurate clinical identification and prompt treatment.

Methods: For this systematic review, we searched PubMed for all studies published in English between Jan 1, 2005, and Oct 7, 2017, to identify individually reported adult patients (≥18 years) who satisfied consensus criteria for definite NMDAR-antibody encephalitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(19)30001-XDOI Listing
February 2019

A transdiagnostic pattern of psychiatric symptoms in autoimmune encephalitis.

Authors:
Carsten Finke

Lancet Psychiatry 2019 Feb 11. Epub 2019 Feb 11.

Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin 10115, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(19)30038-0DOI Listing
February 2019

Genetic clusters and transmission in transgender women.

Lancet HIV 2019 Feb 11. Epub 2019 Feb 11.

International Clinical Research Center, Department of Global Health, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30365-5DOI Listing
February 2019

HIV transmission networks among transgender women in Los Angeles County, CA, USA: a phylogenetic analysis of surveillance data.

Lancet HIV 2019 Feb 11. Epub 2019 Feb 11.

Department of Medicine, University of California, San Diego, CA, USA.

Background: Transgender women are among the groups at highest risk for HIV infection, with a prevalence of 27·7% in the USA; and despite this known high risk, undiagnosed infection is common in this population. We set out to identify transgender women and their partners in a molecular transmission network to prioritise public health activities.

Methods: Since 2006, HIV protease and reverse transcriptase gene (pol) sequences from drug resistance testing have been reported to the Los Angeles County Department of Public Health and linked to demographic data, gender, and HIV transmission risk factor data for each case in the enhanced HIV/AIDS Reporting System. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(18)30359-XDOI Listing
February 2019

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.

Lancet Gastroenterol Hepatol 2019 Feb 11. Epub 2019 Feb 11.

Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada. Electronic address:

Background: Hospitalisation rates for inflammatory bowel disease (IBD) vary across the world. We aimed to investigate temporal patterns of hospitalisation for IBD in member countries of the Organisation for Economic Co-operation and Development (OECD).

Methods: From the OECD database, we assessed IBD-related hospitalisation rates (expressed as annual rates per 100 000 inhabitants) for 34 countries from 1990 to 2016. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24681253193001
Publisher Site
http://dx.doi.org/10.1016/S2468-1253(19)30013-5DOI Listing
February 2019
1 Read

IBD hospitalisation trends provide insight for future study.

Lancet Gastroenterol Hepatol 2019 Feb 11. Epub 2019 Feb 11.

Division of Gastroenterology & Hepatology, Stanford University School of Medicine, Stanford, CA 94063, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30037-8DOI Listing
February 2019

Benefits of laparoscopy in selected cases of small bowel obstruction.

Authors:
Tom Wiggins

Lancet Gastroenterol Hepatol 2019 Feb 11. Epub 2019 Feb 11.

Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24681253193003
Publisher Site
http://dx.doi.org/10.1016/S2468-1253(19)30036-6DOI Listing
February 2019
1 Read

Laparoscopic versus open adhesiolysis for adhesive small bowel obstruction (LASSO): an international, multicentre, randomised, open-label trial.

Lancet Gastroenterol Hepatol 2019 Feb 11. Epub 2019 Feb 11.

Department of Abdominal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Background: Although laparoscopic adhesiolysis for adhesive small bowel obstruction is being done more frequently, it is not widely accepted due to the lack of supporting evidence of its superiority over an open approach and concerns regarding its benefits. We aimed to investigate whether laparoscopic adhesiolysis was a superior treatment for adhesive small bowel obstruction compared with an open approach in terms of length of postoperative hospital stay and morbidity.

Methods: In this international, multicentre, parallel, open-label trial, we randomly assigned patients (1:1) aged 18-95 years who had adhesive small bowel obstruction that had not resolved with conservative management to have either open or laparoscopic adhesiolysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30016-0DOI Listing
February 2019

Improving the outcomes of checkpoint inhibitors in breast cancer.

Authors:
George E Peoples

Lancet Oncol 2019 Feb 11. Epub 2019 Feb 11.

Uniformed Services University of the Health Sciences, Bethesda, MD, USA; MD Anderson Cancer Center, Houston, TX, USA; Cancer Insight, San Antonio, TX 78208, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30068-3DOI Listing
February 2019

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.

Lancet Oncol 2019 Feb 11. Epub 2019 Feb 11.

Institut Gustave Roussy, Université Paris Sud, INSERM U981, Villejuif, France.

Background: HER2-positive breast cancers usually contain large amounts of T-cell infiltrate. We hypothesised that trastuzumab resistance in HER2-positive breast cancer could be mediated by immune mechanisms. We assessed the safety and anti-tumour activity of pembrolizumab, a programmed cell death protein 1 (PD-1) inhibitor, added to trastuzumab in trastuzumab-resistant, advanced HER2-positive breast cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30812-XDOI Listing
February 2019

Lung function trajectories in health and disease.

Lancet Respir Med 2019 Feb 11. Epub 2019 Feb 11.

August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Barcelona, Spain; Centro de Investigación Biomédica en Red, Enfermedades Respiratorias, Instituto de Salud Carlos III (CIBER), Madrid, Spain.

The normal lung function trajectory from birth to death has three phases: a growth phase (from birth to early adulthood), a plateau phase (that lasts for a few years), and a decline phase resulting from physiological lung ageing. Numerous genetic and environmental factors can alter one or more of these phases. Evidence shows that several lung function trajectories exist throughout the life course and, importantly, that some of them are associated with substantial implications for health and disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30529-0DOI Listing
February 2019

Long-term protection against varicella with two-dose combination measles-mumps-rubella-varicella vaccine.

Lancet Infect Dis 2019 Feb 11. Epub 2019 Feb 11.

National Centre for Immunisation Research and Surveillance, Westmead, NSW 2145, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(18)30797-7DOI Listing
February 2019

Unrecognised Ebola virus infection in contact persons: what can we learn from it?

Lancet Infect Dis 2019 Feb 11. Epub 2019 Feb 11.

UK Public Health Rapid Support Team, London School of Hygiene and Tropical Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(18)30689-3DOI Listing
February 2019